Price Alert

Biomea Fusion Inc. (BMEA)

NASDAQ: BMEA · Real-Time Price · USD

1.59

-0.06 (-3.64%)

At close: Oct 16, 2025, 3:59 PM

1.59

0.14%

After-hours: Oct 16, 2025, 07:18 PM EDT

-3.64% (1D)

Bid	1.59
Market Cap	94.6M
Revenue (ttm)	1.22M
Net Income (ttm)	-112.09M
EPS (ttm)	-3
PE Ratio (ttm)	-0.53
Forward PE	-1.21
Analyst	Buy
Dividends	n/a

Ask	1.65
Volume	1,271,965
Avg. Volume (20D)	1,442,729
Open	1.65
Previous Close	1.65
Day's Range	1.59 - 1.69
52-Week Range	1.29 - 12.85
Beta	-0.14
Ex-Dividend Date	n/a

About BMEA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BMEA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BMEA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

-30.71%

Biomea Fusion shares are trading lower after the c... Unlock content with Pro Subscription

1 week ago

+24.19%

Biomea Fusion shares are trading higher after the company announced 52-week results from its Phase II COVALENT-111 study evaluating the efficacy, safety, and tolerability of icovamenib in patients with type 2 diabetes.

News

1 week ago · seekingalpha.com

Biomea Fusion, Inc. - Special Call

Biomea Fusion, Inc. - Special Call Company Participants Ramses Erdtmann - Co-Founder, President, COO & Director Michael J. Hitchcock - Interim CEO & Director Stephan Morris - Chief Development Officer...

1 week ago · benzinga.com

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

Biomea Fusion Inc‘s (NASDAQ:BMEA) stock price plummeted after the company priced its public offering.

2 months ago · fool.com

Biomea Fusion (BMEA) Q2 Loss Drops 44%

2 months ago · https://thefly.com

Biomea Fusion price target lowered to $9 from $10 at Oppenheimer

Oppenheimer analyst Matthew Biegler lowered the firm's price target on Biomea Fusion to $9 from $10 and keeps an Outperform rating on the shares. The firm is updating its model following the company's...